Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

Merck Second Quarter Profit More Than Doubles

July 29, 2014 | by The Associated Press | Comments

Merck has reported earnings that more than doubled in its second quarter, and topped analysts' expectations. The Whitehouse Station, New Jersey-based company said net income increased to $2 billion, or 68 cents per share, from $906 million, or 30 cents per share, in the same quarter a year earlier.

TOPICS:

Pfizer's Second Quarter Profit Sinks 79% But Tops Forecasts

July 29, 2014 8:30 am | Comments

Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.  

TOPICS:

Corning Second Quarter Profit Falls 74%

July 29, 2014 8:21 am | Comments

The Corning, New York-based company said earnings fell to $169 million, or 11 cents per share, from $638 million, or 43 cents per share, in the same quarter a year ago.              

TOPICS:

FDA Inspects Impax's Taiwan Facility – Finds Ten Issues

July 29, 2014 8:11 am | Comments

Impax Laboratories announced that the FDA performed a general GMP  inspection and a Pre-Approval Inspection for RYTARY at the company's Taiwan manufacturing facility from July 21 to July 26, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with ten inspectional observations.

TOPICS:
Advertisement

FDA Grants Full Approval for IMBRUVICA for Two Indications

July 28, 2014 2:39 pm | Comments

Pharmacyclics, Inc. announced that the FDA has granted IMBRUVICA regular (full) approval for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy, and for the treatment of CLL patients with deletion of the short arm of chromosome 17 (del 17p CLL), including treatment naive and previously treated del 17p CLL patients.

TOPICS:

PaxVax Acquires FDA-Approved Typhoid Vaccine Vivotif

July 28, 2014 9:19 am | Comments

PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that it has acquired the oral typhoid vaccine Vivotif® from Crucell Switzerland AG, as well as its manufacturing facility in Thörishaus, near Bern, Switzerland.

TOPICS:

FDA Approves Aqua Pharmaceuticals' ACTICLATE™ Tablets

July 28, 2014 9:11 am | Comments

ACTICLATE™ is a tetracycline-class antibacterial indicated for the treatment of a number of infections, including adjunctive therapy in severe acne.                 

TOPICS:

Ortho-Clinical Diagnostics and Astute Medical to Develop Acute Kidney Injury Tests

July 28, 2014 9:06 am | Comments

Ortho-Clinical Diagnostics has entered into a strategic partnership with Astute Medical, under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK ® Test and ASTUTE140 ® Meter in certain markets in Europe and, pending FDA clearance, the United States.

TOPICS:

AstraZeneca and QIAGEN to Develop Diagnostic Test for Lung Cancer Patients Suitable for Treatment with IRESSA

July 28, 2014 8:49 am | Comments

AstraZeneca today announced that it has entered into a collaboration with Netherlands-based QIAGEN to develop a non-invasive diagnostic test to identify non-small cell lung cancer (NSCLC) patients who are suitable for treatment with IRESSA®.  

TOPICS:
Advertisement

Two Americans Have Ebola in Liberia

July 28, 2014 8:32 am | Comments

Two American aid workers have tested positive for the Ebola virus while working to combat an outbreak of the deadly disease at a hospital in Liberia, a relief group official said.            

TOPICS:

After Six Weeks, Finally a Deal on VA Health Care

July 28, 2014 8:26 am | by MATTHEW DALY, Associated Press | Comments

After more than six weeks of sometimes testy talks, House and Senate negotiators have agreed on a compromise plan to fix a veterans health program scandalized by long patient wait times and falsified records covering up delays.    

TOPICS:

Fist Bumps Less Germy Than Handshakes, Study Says

July 28, 2014 8:20 am | by MIKE STOBBE, AP Medical Writer | Comments

When it comes to preventing the spread of germs, maybe the president is on to something with his fondness for fist bumps.                      

TOPICS:

Arizona Execution Renews Debate Over Methods

July 28, 2014 8:14 am | by PAUL ELIAS, Associated Press | Comments

A third execution by lethal injection has gone awry in six months, renewing debate over whether there is a foolproof way for the government to humanely kill condemned criminals, and whether it's even worth looking for one.     

TOPICS:

MedImmune Fights Pediatricians' New Advice

July 28, 2014 8:11 am | by LINDSEY TANNER, AP Medical Writer | Comments

A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine.         

TOPICS:

AstraZeneca and Roche to Develop Companion Diagnostic Test for AZD9291

July 28, 2014 7:57 am | Comments

AstraZeneca today announced it has entered into collaboration with Roche to develop a plasma-based companion diagnostic test to support AZD9291, AstraZeneca’s investigational compound in clinical development for non-small-cell lung cancer (NSCLC).

TOPICS:

AbbVie Second Quarter Profit Climbs 2.8%

July 25, 2014 1:41 pm | Comments

AbbVie's second-quarter profit increased nearly 3 percent and beat analysts' expectations, as sales soared for the world's top-selling drug, Humira.                

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading